Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Anticancer Research
|
May 1, 2001
The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence
L Holubec, O Topolcan, R Pikner, et al.
Clinical Chemistry
|
July 27, 2001
Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?
A Semjonow, F Oberpenning, C Weining, et al.
Anticancer Research
|
July 23, 2005
Clinical relevance of tumor markers for the control of chemotherapy
J Finek, L Holubec, O Topolcan, et al.
Anticancer Research
|
July 1, 1997
The ratio of free to total prostate specific antigen: an advantageous addition in the differential diagnosis of benign hyperplasia and cancer of the prostate?
W Reiter, P Stieber, N Schmeller, et al.
Onkologie
|
November 8, 2003
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
J Stemmler, P Stieber, A M Szymala, et al.
The Prostate
|
May 8, 2001
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis
M Lein, K Jung, P Hammerer, et al.
Anticancer Research
|
July 22, 2005
Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma
L Holubec, O Topolcan, J Finek, et al.
European Journal of Gynaecological Oncology
|
January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up
A van Dalen, J Favier, E Hallensleben, et al.
Gut
|
October 15, 2008
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population
A Graser, P Stieber, D Nagel, et al.
Clinical Chemistry
|
November 24, 2001
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay
P Stieber, R Molina, D W Chan, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Anticancer Research
|
May 1, 2001
The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence
L Holubec, O Topolcan, R Pikner, et al.
Clinical Chemistry
|
July 27, 2001
Do modifications of nonequimolar assays for total prostate-specific antigen improve detection of prostate cancer?
A Semjonow, F Oberpenning, C Weining, et al.
Anticancer Research
|
July 23, 2005
Clinical relevance of tumor markers for the control of chemotherapy
J Finek, L Holubec, O Topolcan, et al.
Anticancer Research
|
July 1, 1997
The ratio of free to total prostate specific antigen: an advantageous addition in the differential diagnosis of benign hyperplasia and cancer of the prostate?
W Reiter, P Stieber, N Schmeller, et al.
Onkologie
|
November 8, 2003
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
J Stemmler, P Stieber, A M Szymala, et al.
The Prostate
|
May 8, 2001
A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis
M Lein, K Jung, P Hammerer, et al.
Anticancer Research
|
July 22, 2005
Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma
L Holubec, O Topolcan, J Finek, et al.
European Journal of Gynaecological Oncology
|
January 27, 2010
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up
A van Dalen, J Favier, E Hallensleben, et al.
Gut
|
October 15, 2008
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population
A Graser, P Stieber, D Nagel, et al.
Clinical Chemistry
|
November 24, 2001
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay
P Stieber, R Molina, D W Chan, et al.
Page
of 9